Home

The Future of the Cath Lab: Managing Complexity for Improved Safety and Outcomes in CTO, TAVI, and Carotid Intervention

Drs. Roxanna Mehran, Jeffrey Moses, and John Laird summarize recent clinical evidence and apply strategies to reduce the risk of contrast induce nephropathy in complex cases: TAVI, CTO, and Carotid Artery Stenting.

Want to know more about hemodynamic assist?

Dr. Richard Smalling hosts a fascinating, accredited on-demand webcast exploring the role of hemodynamic assist in cardiogenic shock and high-risk interventions. Access This Course at Your Convenience!

Access Now »

News View More

  • Mortality Rates Are Greater in Women Admitted for MI without Chest Pain
    02/22/12
    In the February issue of the Journal of the American Medical Association, meta-analysis data indicate that there is a greater mortality risk for women admitted for myocardial infarction without the presence of chest pain. Watson Clinic and Lakeland Regional Medical Center researchers noted this difference when assessing over 1 million patients from the National Registry of Myocardial Infarction, comparing MI rates between sex, age, and presence of chest pain among documented cases from 1994 to 2006. Read More »
  • Mental State Linked to Physical Heart Health
    02/16/12
     Researchers from Tel Aviv University found that mental state, specifically depression, made heart attack patients more likely to be readmitted for cardiac events and chest pain. Read More »
  • BH4 Boosts Vascular Health in Postmenopausal Women
    02/15/12
     University of Colorado School of Medicine researchers found that in postmenopausal women, stiffening of arteries—which can increase the risk of stroke and heart disease—could be decreased with the introduction of tetrahydrobiopterin,  also referred to as BH4. Read More »